Analyst Rating Update on Hill-Rom Holdings Inc (HRC)

Hill-Rom Holdings Inc (NYSE:HRC) : 6 analysts are covering Hill-Rom Holdings Inc (NYSE:HRC) and their average rating on the stock is 1.75, which is read as a Buy. 3 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Hill-Rom Holdings Inc (NYSE:HRC) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 2 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Hill-Rom Holdings Inc (NYSE:HRC) stock is expected to deviate a maximum of $4.97 from the average target price of $62 for the short term period. 4 Street Experts have initiated coverage on the stock with the most promising target being $69 and the most muted being $58.

For the current week, the company shares have a recommendation consensus of Buy.

Hill-Rom Holdings Inc (NYSE:HRC): On Tuesdays trading session , Opening price of the stock was $48.3 with an intraday high of $48.845. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $47.76. However, the stock managed to close at $48.06, a loss of 0.62% for the day. On the previous day, the stock had closed at $48.36. The total traded volume of the day was 792,086 shares.

In an insider trading activity,The (VP, Controller & CAO) of Hill-Rom Holdings, Inc., Richardson Jason sold 2,952 shares at $47.8 on May 13, 2016. The Insider selling transaction had a total value worth of $141,106. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

Hill-Rom Holdings, Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. The Company operates in three segments: North America, Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services, as well as its clinical workflow solutions, in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.